Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023473 (
chronic myeloid leukemia
)
18,916
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Neutral Cholesterol Ester Hydrolase 1 (NCEH1) is an enzyme involved in ether lipid metabolism, and the
NCEH1
gene is overexpressed in a variety of tumors. However, its role in
pancreatic cancer
remains unknown. Therefore, we compared the gene transcription data of healthy and
pancreatic cancer
tissues using the Cancer Genome Atlas and Genotype-Tissue Expression databases. R software (v3.6.1) was used for the differential, clinicopathological correlation, and survival analyses. We found that
NCEH1
was overexpressed in
pancreatic cancer
tissues compared with that in healthy tissues (
P
= 1.732 e-50), and that its expression level was related to lymph node metastasis. High
NCEH1
expression was associated with poor overall survival (
P
= 0.002). Using univariate and multivariate Cox regression analyses, we determined that
NCEH1
is an independent risk factor for
pancreatic cancer
. Gene set enrichment analysis identified that
NCEH1
overexpression is prominent in cell-cell adhesion junctions,
pancreatic cancer
, cancer-associated pathways, prostate cancer, and
chronic myeloid leukemia
. In contrast, low
NCEH1
expression correlated to high oxidative phosphorylation. Thus, we conclude that
NCEH1
may be a prognostic biomarker for
pancreatic cancer
.
...
PMID:NCEH1 may be a prognostic biomarker for pancreatic cancer. 3328 89
<< Previous
1
2
3
4